Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
Sadia WaheedNeurology, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USAAngel BayasNeurology, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USAFawzi HindiNeurology, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USAZufe RizviNeurology, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USAPatricio S EspinosaNeurology, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USA
2021en
ABI
Аннотация
Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications. In December 2020, two vaccines have been approved in the United States for the prevention of COVID-19. We report a case of Guillain-Barre Syndrome (GBS) after receiving the first dose of Pfizer - COVID-19 vaccine.
Ҳали таржима қилинмаган
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба